(Z)-2-Cyano-3-cyclopropyl-N-(4'-fluoro-biphenyl-4-yl)-3-hydroxy-acrylamide

ID: ALA142997

Max Phase: Preclinical

Molecular Formula: C19H15FN2O2

Molecular Weight: 322.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#C/C(C(=O)Nc1ccc(-c2ccc(F)cc2)cc1)=C(/O)C1CC1

Standard InChI:  InChI=1S/C19H15FN2O2/c20-15-7-3-12(4-8-15)13-5-9-16(10-6-13)22-19(24)17(11-21)18(23)14-1-2-14/h3-10,14,23H,1-2H2,(H,22,24)/b18-17-

Standard InChI Key:  FABSQWSOOLARBU-ZCXUNETKSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
    5.2292   -5.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7125   -5.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7542   -5.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2750   -5.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2292   -5.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1917   -5.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2292   -6.5417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5667   -5.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8667   -5.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7042   -4.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3917   -5.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7917   -5.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5875   -5.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6917   -4.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6917   -5.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4917   -4.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4917   -5.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7542   -4.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5917   -5.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2875   -5.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2875   -4.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8917   -5.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8917   -4.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0083   -5.3292    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  3  1  0
  5  1  1  0
  6  2  1  0
  7  5  3  0
  8  4  1  0
  9  4  1  0
 10  2  2  0
 11 14  1  0
 12 11  1  0
 13  6  1  0
 14 21  2  0
 15 20  1  0
 16 12  2  0
 17 12  1  0
 18  3  1  0
 19 22  1  0
 20 13  2  0
 21 13  1  0
 22 17  2  0
 23 16  1  0
 24 19  1  0
  8  9  1  0
 11 15  2  0
 23 19  2  0
M  END

Alternative Forms

  1. Parent:

    ALA142997

    ---

Associated Targets(non-human)

Dhodh Dihydroorotate dehydrogenase (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dhodh Dihydroorotate dehydrogenase (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 322.34Molecular Weight (Monoisotopic): 322.1118AlogP: 4.18#Rotatable Bonds: 4
Polar Surface Area: 73.12Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 5.98CX Basic pKa: CX LogP: 3.47CX LogD: 2.04
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.50Np Likeness Score: -1.36

References

1. Kuo EA, Hambleton PT, Kay DP, Evans PL, Matharu SS, Little E, McDowall N, Jones CB, Hedgecock CJ, Yea CM, Chan AW, Hairsine PW, Ager IR, Tully WR, Williamson RA, Westwood R..  (1996)  Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotate dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4'-(trifluoromethyl)phenyl ] propenamide and related compounds.,  39  (23): [PMID:8917650] [10.1021/jm9604437]

Source